245 related articles for article (PubMed ID: 30909355)
1. Disorders of Hypopigmentation.
Dina Y; McKesey J; Pandya AG
J Drugs Dermatol; 2019 Mar; 18(3):s115-s116. PubMed ID: 30909355
[TBL] [Abstract][Full Text] [Related]
2. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.
Liu LY; Strassner JP; Refat MA; Harris JE; King BA
J Am Acad Dermatol; 2017 Oct; 77(4):675-682.e1. PubMed ID: 28823882
[TBL] [Abstract][Full Text] [Related]
3. [Systemic treatment of vitiligo : Balance and current developments].
Meurer M; Ceric-Dehdari P
Hautarzt; 2017 Nov; 68(11):876-884. PubMed ID: 29030646
[TBL] [Abstract][Full Text] [Related]
4. Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy.
Craiglow BG; King BA
JAMA Dermatol; 2015 Oct; 151(10):1110-2. PubMed ID: 26107994
[TBL] [Abstract][Full Text] [Related]
5. Rapid Repigmentation of Vitiligo Using Tofacitinib Plus Low-Dose, Narrowband UV-B Phototherapy.
Kim SR; Heaton H; Liu LY; King BA
JAMA Dermatol; 2018 Mar; 154(3):370-371. PubMed ID: 29387870
[No Abstract] [Full Text] [Related]
6. Vitiligo.
Ezzedine K; Eleftheriadou V; Whitton M; van Geel N
Lancet; 2015 Jul; 386(9988):74-84. PubMed ID: 25596811
[TBL] [Abstract][Full Text] [Related]
7. Janus kinase inhibitors in dermatology: A systematic review.
Shreberk-Hassidim R; Ramot Y; Zlotogorski A
J Am Acad Dermatol; 2017 Apr; 76(4):745-753.e19. PubMed ID: 28169015
[TBL] [Abstract][Full Text] [Related]
8. Controversial issues in vitiligo patients: a review of old and recent treatments.
Lotti T; Gianfaldoni S; Valle Y; Rovesti M; Feliciano C; Satolli F
Dermatol Ther; 2019 Jan; 32(1):e12745. PubMed ID: 30221810
[TBL] [Abstract][Full Text] [Related]
9. New and experimental treatments of vitiligo and other hypomelanoses.
Lotti T; Prignano F; Buggiani G
Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
[TBL] [Abstract][Full Text] [Related]
10. Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis.
Phan K; Phan S; Shumack S; Gupta M
J Dermatolog Treat; 2022 Feb; 33(1):173-177. PubMed ID: 32096671
[TBL] [Abstract][Full Text] [Related]
11. Medical and Maintenance Treatments for Vitiligo.
Passeron T
Dermatol Clin; 2017 Apr; 35(2):163-170. PubMed ID: 28317526
[TBL] [Abstract][Full Text] [Related]
12. Vitiligo nonsurgical treatment: a review of latest treatment researches.
Zhang Y; Mooneyan-Ramchurn JS; Zuo N; Feng Y; Xiao S
Dermatol Ther; 2014; 27(5):298-303. PubMed ID: 25041437
[TBL] [Abstract][Full Text] [Related]
13. Comparison between autologous noncultured epidermal cell suspension and suction blister epidermal grafting in stable vitiligo: a randomized study.
Budania A; Parsad D; Kanwar AJ; Dogra S
Br J Dermatol; 2012 Dec; 167(6):1295-301. PubMed ID: 22897617
[TBL] [Abstract][Full Text] [Related]
14. Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata.
Bayart CB; DeNiro KL; Brichta L; Craiglow BG; Sidbury R
J Am Acad Dermatol; 2017 Jul; 77(1):167-170. PubMed ID: 28619556
[No Abstract] [Full Text] [Related]
15. Management of vitiligo patients with surgical interventions.
Shokeen D
Cutis; 2016 May; 97(5):E27-9. PubMed ID: 27274556
[TBL] [Abstract][Full Text] [Related]
16. Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature.
Samadi A; Ahmad Nasrollahi S; Hashemi A; Nassiri Kashani M; Firooz A
J Dermatolog Treat; 2017 Sep; 28(6):476-483. PubMed ID: 28024126
[TBL] [Abstract][Full Text] [Related]
17. Vitiligo: an update on systemic treatments.
Searle T; Al-Niaimi F; Ali FR
Clin Exp Dermatol; 2021 Mar; 46(2):248-258. PubMed ID: 33350506
[TBL] [Abstract][Full Text] [Related]
18. A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo.
McKesey J; Pandya AG
J Am Acad Dermatol; 2019 Aug; 81(2):646-648. PubMed ID: 31009664
[No Abstract] [Full Text] [Related]
19. Partial repigmentation of vitiligo with tofacitinib, without exposure to ultraviolet radiation.
Komnitski M; Komnitski A; Komnitski Junior A; Silva de Castro CC
An Bras Dermatol; 2020; 95(4):473-476. PubMed ID: 32418716
[TBL] [Abstract][Full Text] [Related]
20. Vitiligo: current medical and scientific understanding.
Boissy RE; Nordlund JJ
G Ital Dermatol Venereol; 2011 Feb; 146(1):69-75. PubMed ID: 21317859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
